telavancin
Selected indexed studies
- Telavancin. (, 2006) [PMID:29999745]
- Telavancin: a novel lipoglycopeptide. (Clin Infect Dis, 2009) [PMID:19911938]
- Telavancin: a novel lipoglycopeptide antimicrobial agent. (Am J Health Syst Pharm, 2007) [PMID:17989443]
_Worker-drafted node — pending editorial review._
Connections
telavancin is a side effect of
Sources
- Telavancin. (2006) pubmed
- Telavancin: a novel lipoglycopeptide. (2009) pubmed
- Telavancin: a novel lipoglycopeptide antimicrobial agent. (2007) pubmed
- Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens. (2017) pubmed
- Telavancin: TD 6424, TD-6424. (2006) pubmed
- Telavancin (Theravance). (2005) pubmed
- Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review. (2020) pubmed
- Telavancin: a novel lipoglycopeptide for serious gram-positive infections. (2007) pubmed
- Telavancin. (2009) pubmed
- Telavancin: a new lipoglycopeptide for gram-positive infections. (2009) pubmed